The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine
Open accessAbstract
Background: Currently available anti-influenza drugs are often associated with limitations such as toxicity and the appearance of drug-resistant strains. Therefore, there is a pressing need for the development of novel, safe and more efficient antiviral agents. In this study, we evaluated the antiviral activity of zinc oxide nanoparticles (ZnO-NPs) and PEGylated zinc oxide nanoparticles against H1N1 influenza virus. Methods: The nanoparticles were characterized using the inductively coupled plasma mass spectrometry, x-ray diffraction analysis, and electron microscopy. MTT assay was applied to assess the cytotoxicity of the nanoparticles, and anti-influenza activity was determined by TCID50 and quantitative Real-Time PCR assays. To study the inhibitory impact of nanoparticles on the expression of viral antigens, an indirect immunofluorescence assay was also performed. Results: Post-exposure of influenza virus with PEGylated ZnO-NPs and bare ZnO-NPs at the highest non-toxic concentrations could be led to 2.8 and 1.2 log10 TCID50 reduction in virus titer when compared to the virus control, respectively (P < 0.0001). At the highest non-toxic concentrations, the PEGylated and unPEGylated ZnO-NPs led to inhibition rates of 94.6% and 52.2%, respectively, which were calculated based on the viral loads. There was a substantial decrease in fluorescence emission intensity in viral-infected cell treated with PEGylated ZnO-NPs compared to the positive control. Conclusions: Taken together, our study indicated that PEGylated ZnO-NPs could be a novel, effective, and promising antiviral agent against H1N1 influenza virus infection, and future studies can be designed to explore the exact antiviral mechanism of these nanoparticles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
Properties of Zinc Oxide Nanoparticles and Their Activity Against Microbes
Siddiqi, K. S., ur Rahman, A., Tajuddin, & Husen, A. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2532-3 · Cited by 1,057
Biological mechanisms of gold nanoparticle radiosensitization
Rosa, S., Connolly, C., Schettino, G., Butterworth, K. T., & Prise, K. M. (2017) · Cancer Nanotechnology · doi:10.1186/s12645-017-0026-0 · Cited by 260
Ding, Y., Cao, Z., Cao, L., Ding, G., Wang, Z., & Xiao, W. (2017) · Scientific Reports · doi:10.1038/srep45723 · Cited by 214
Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus
Kumar, R., Nayak, M., Sahoo, G. C., Pandey, K., Sarkar, M. C., Ansari, Y., Das, V. N. R., Topno, R. K., Bhawna, Madhukar, M., et al. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2018.12.006 · Cited by 191
Preparation of ZnO Nanostructures by Chemical Precipitation Method
Khoshhesab, Z. M., Sarfaraz, M., & Asadabad, M. A. (2011) · Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry · doi:10.1080/15533174.2011.591308 · Cited by 171
Tavakoli, A., Ataei‐Pirkooh, A., Sadeghi, G. M. M., Bokharaei‐Salim, F., Sahrapour, P., Kiani, S. J., Moghoofei, M., Farahmand, M., Javanmard, D., & Monavari, S. H. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0089 · Cited by 152
Self-citationLi, Y.-H., Lin, Z.-F., Guo, M., Xia, Y., Zhao, M.-Q., Wang, C.-B., Xu, T.-T., Chen, T., & Zhu, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140939 · Cited by 127
Antimicrobial Activities of Metal Nanoparticles
Brandelli, A., Ritter, A. C., & Veras, F. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-63790-7_15 · Cited by 92
Nguyen, J. T., Smee, D. F., Barnard, D. L., Julander, J. G., Gross, M. I., de Jong, M. D., & Went, G. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031006 · Cited by 90
Cited by
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
Gupta, R., Ghosh, A., Singh, A. K., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.002 · Cited by 518
Wojnarowicz, J., Chudoba, T., & Lojkowski, W. (2020) · Nanomaterials · doi:10.3390/nano10061086 · Cited by 361
Nanoparticles as antimicrobial and antiviral agents: A literature-based perspective study
Sharmin, S., Rahaman, M. M., Sarkar, C., Atolani, O., Islam, M. T., & Adeyemi, O. S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06456 · Cited by 338
Mandal, A. K., Katuwal, S., Tettey, F., Gupta, A., Bhattarai, S., Jaisi, S., Bhandari, D. P., Shah, A. K., Bhattarai, N., & Parajuli, N. (2022) · Nanomaterials · doi:10.3390/nano12173066 · Cited by 321
COVID-19: Poor outcomes in patients with zinc deficiency
Jothimani, D., Kailasam, E., Danielraj, S., Nallathambi, B., Ramachandran, H., Sekar, P., Manoharan, S., Ramani, V., Narasimhan, G., Kaliamoorthy, I., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.014 · Cited by 296
Metadata
- Authors
- Ghaffari, H., Tavakoli, A., Moradi, A., Tabarraei, A., Bokharaei-Salim, F., Zahmatkeshan, M., Farahmand, M., Javanmard, D., Kiani, S. J., Esghaei, M., Pirhajati-Mahabadi, V., Monavari, S. H., & Ataei-Pirkooh, A.
- Venue
- Journal of Biomedical Science
- Published
- 2019-09-10
- Volume
- 26
- Issue
- 1
- Pages
- 70-70
- ISSN
- 1021-7770 (ISSN-L)
- 1423-0127
- OpenAlex
- W2972743302
- Cited by
- 392
- References
- 19
- FWCI
- 20.67
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. https://app.cochat.ai/papers/10.1186/s12929-019-0563-4
- The paper
- Ghaffari, H., Tavakoli, A., Moradi, A., Tabarraei, A., Bokharaei-Salim, F., Zahmatkeshan, M., Farahmand, M., Javanmard, D., Kiani, S. J., Esghaei, M., Pirhajati-Mahabadi, V., Monavari, S. H., & Ataei-Pirkooh, A. (2019). Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. Journal of Biomedical Science. https://doi.org/10.1186/s12929-019-0563-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.